Compare, Analyse Sterling Biotech with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ACTAVIS (US) - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ACTAVIS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ACTAVIS
Dec-18
STERLING BIOTECH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1114,578-   
Low Rs39,779-   
Sales per share (Unadj.) Rs26.83,576.0-  
Earnings per share (Unadj.) Rs-15.0-1,151.8-  
Cash flow per share (Unadj.) Rs-5.5376.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.914,749.5-  
Shares outstanding (eoy) m267.87332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 7.6%   
Avg P/E ratio x-0.5-10.6 4.4%  
P/CF ratio (eoy) x-1.332.3 -3.9%  
Price / Book Value ratio x0.10.8 15.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8624,050,639 0.0%   
No. of employees `0001.416.9 8.0%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.370,378.3 7.5%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.0-22,668.9 13.1%   
INCOME DATA
Net Sales Rs m7,1811,189,393 0.6%  
Other income Rs m4322,745 0.2%   
Total revenues Rs m7,2231,212,138 0.6%   
Gross profit Rs m94731,168 3.0%  
Depreciation Rs m2,543508,440 0.5%   
Interest Rs m4,37768,635 6.4%   
Profit before tax Rs m-5,931-523,161 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0133,427 0.0%   
Tax Rs m-1,924-6,630 29.0%   
Profit after tax Rs m-4,007-383,104 1.0%  
Gross profit margin %13.22.6 503.2%  
Effective tax rate %32.41.3 2,560.3%   
Net profit margin %-55.8-32.2 173.2%  
BALANCE SHEET DATA
Current assets Rs m14,335487,827 2.9%   
Current liabilities Rs m49,809431,548 11.5%   
Net working cap to sales %-494.04.7 -10,440.6%  
Current ratio x0.31.1 25.5%  
Inventory Days Days40320 2,059.7%  
Debtors Days Days17166 257.3%  
Net fixed assets Rs m55,432134,633 41.2%   
Share capital Rs m2680-   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7014,905,689 0.3%   
Long term debt Rs m9,4781,727,471 0.5%   
Total assets Rs m73,9887,668,708 1.0%  
Interest coverage x-0.4-6.6 5.4%   
Debt to equity ratio x0.60.4 183.1%  
Sales to assets ratio x0.10.2 62.6%   
Return on assets %0.5-4.1 -12.2%  
Return on equity %-27.3-7.8 349.0%  
Return on capital %-6.4-4.8 132.7%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719424,925 0.4%  
From Investments Rs m-3,148233,441 -1.3%  
From Financial Activity Rs m1,426-729,299 -0.2%  
Net Cashflow Rs m-3-70,579 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 75.34 Rs / USD

Compare STERLING BIOTECH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: AJANTA PHARMA  SUVEN LIFE SCIENCES  NOVARTIS  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS